These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 33098230)

  • 21. Direct or Collateral Liver Damage in SARS-CoV-2-Infected Patients.
    Lizardo-Thiebaud MJ; Cervantes-Alvarez E; Limon-de la Rosa N; Tejeda-Dominguez F; Palacios-Jimenez M; Méndez-Guerrero O; Delaye-Martinez M; Rodriguez-Alvarez F; Romero-Morales B; Liu WH; Huang CA; Kershenobich D; Navarro-Alvarez N
    Semin Liver Dis; 2020 Aug; 40(3):321-330. PubMed ID: 32886936
    [TBL] [Abstract][Full Text] [Related]  

  • 22. COVID-19-associated liver injury (COVALI): role of hepatologists.
    Sumida Y; Yoneda M
    J Gastroenterol; 2021 Aug; 56(8):786-787. PubMed ID: 34212231
    [No Abstract]   [Full Text] [Related]  

  • 23. COVID-19 and hepatic involvement: The liver as a main actor of the pandemic novel.
    Napodano C; Pocino K; Stefanile A; Marino M; Miele L; Gulli F; Basile V; Pandolfi F; Gasbarrini A; Rapaccini GL; Basile U
    Scand J Immunol; 2021 Mar; 93(3):e12977. PubMed ID: 32931622
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Correlation analysis of coagulation dysfunction and liver damage in patients with novel coronavirus pneumonia: a single-center, retrospective, observational study.
    Chen S; Liu H; Li T; Huang R; Gui R; Zhang J
    Ups J Med Sci; 2020 Nov; 125(4):293-296. PubMed ID: 32990149
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Etiology and management of liver injury in patients with COVID-19.
    Yang RX; Zheng RD; Fan JG
    World J Gastroenterol; 2020 Aug; 26(32):4753-4762. PubMed ID: 32921955
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Gastrointestinal and hepatic manifestations of COVID-19: A comprehensive review.
    Cha MH; Regueiro M; Sandhu DS
    World J Gastroenterol; 2020 May; 26(19):2323-2332. PubMed ID: 32476796
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mild versus Severe Liver Injury in SARS-CoV-2 Infection.
    Anastasiou OE; Korth J; Herbstreit F; Witzke O; Lange CM
    Dig Dis; 2021; 39(1):52-57. PubMed ID: 32777784
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Covid-19 infection, liver injury and prognosis: a suggestion.
    Testino G
    Eur J Gastroenterol Hepatol; 2021 Mar; 33(3):451-452. PubMed ID: 32558696
    [No Abstract]   [Full Text] [Related]  

  • 29. Evaluation of serum hepatic enzyme activities in different COVID-19 phenotypes.
    Liao FL; Peng DH; Chen W; Hu HN; Tang P; Liu YY; Luo Y; Yao T
    J Med Virol; 2021 Apr; 93(4):2365-2373. PubMed ID: 33314141
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Abnormal liver-related biomarkers in COVID-19 patients and the role of prealbumin.
    Li T; Guo Y; Zhuang X; Huang L; Zhang X; Wei F; Yang B
    Saudi J Gastroenterol; 2020; 26(5):272-278. PubMed ID: 32769260
    [TBL] [Abstract][Full Text] [Related]  

  • 31. COVID-19 pandemic: Its impact on liver disease and liver transplantation.
    Sahin TT; Akbulut S; Yilmaz S
    World J Gastroenterol; 2020 Jun; 26(22):2987-2999. PubMed ID: 32587443
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Liver disease and outcomes among COVID-19 hospitalized patients - A systematic review and meta-analysis.
    Sharma A; Jaiswal P; Kerakhan Y; Saravanan L; Murtaza Z; Zergham A; Honganur NS; Akbar A; Deol A; Francis B; Patel S; Mehta D; Jaiswal R; Singh J; Patel U; Malik P
    Ann Hepatol; 2021; 21():100273. PubMed ID: 33075578
    [TBL] [Abstract][Full Text] [Related]  

  • 33. COVID-19 and liver disease: Not all evil comes to harm.
    Marabotto E; Ziola S; Sheijani AD; Giannini EG
    Liver Int; 2021 Jan; 41(1):237-238. PubMed ID: 33159405
    [No Abstract]   [Full Text] [Related]  

  • 34. Clinical characteristics and risk factors for liver injury in COVID-19 patients in Wuhan.
    Zhang H; Liao YS; Gong J; Liu J; Zhang H
    World J Gastroenterol; 2020 Aug; 26(31):4694-4702. PubMed ID: 32884226
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Liver damage at admission is an independent prognostic factor for COVID-19.
    Chen LY; Chu HK; Bai T; Tu SJ; Wei Y; Li ZL; Hu LL; Zhu R; Zhang L; Han CQ; Xiao L; He Q; Song J; Liu WH; Zhu QJ; Chen H; Yang L; Hou XH
    J Dig Dis; 2020 Sep; 21(9):512-518. PubMed ID: 32713118
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Gastrointestinal and liver manifestations of COVID-19.
    Cheong J; Bartell N; Peeraphatdit T; Mosli M; Al-Judaibi B
    Saudi J Gastroenterol; 2020; 26(5):226-232. PubMed ID: 32367837
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Liver Enzyme Elevation in Coronavirus Disease 2019: A Multicenter, Retrospective, Cross-Sectional Study.
    Hao SR; Zhang SY; Lian JS; Jin X; Ye CY; Cai H; Zhang XL; Hu JH; Zheng L; Zhang YM; Jia HY; Yu GD; Wang XY; Gu JQ; Lu YF; Yu XP; Yu L; Xiang DR; Ye CY; Jin CL; Qiu YQ; Li LJ; Sheng JF; Liang TB; Yang YD
    Am J Gastroenterol; 2020 Jul; 115(7):1075-1083. PubMed ID: 32618658
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An updated meta-analysis of AST and ALT levels and the mortality of COVID-19 patients.
    Wang Y; Shi L; Wang Y; Yang H
    Am J Emerg Med; 2021 Feb; 40():208-209. PubMed ID: 32475764
    [No Abstract]   [Full Text] [Related]  

  • 39. USEFULNESS OF SALIVA SAMPLES FOR DETECTING SARS-CoV-2 RNA AMONG LIVER DISEASE PATIENTS.
    Villar LM; da Costa VD; Marques BCL; da Silva LL; Santos AC; Mendonça ACDF; Marques VA; do Nascimento GP; Lewis-Ximenez LL; de Paula VS
    J Infect; 2021 Jan; 82(1):e4-e5. PubMed ID: 32711040
    [No Abstract]   [Full Text] [Related]  

  • 40. No association between COVID-19 related liver injury and the course of disease: a retrospective study.
    Sikkema BJB; Sint Nicolaas JJ; van Wijngaarden PP
    Scand J Gastroenterol; 2021 Jan; 56(1):68-71. PubMed ID: 33119428
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.